Noushin Farnoud

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia”.

A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia

Blood(2022)10.1182/blood.2021012743

N/A

3.6DataRank · unranked

129 citations

Heidi E. Kosiorek, Josef T. Prchal, Alessandro Rambaldi, Dmitriy Berenzon, Abdulraheem Yacoub +38 more

Phase 2 study of ruxolitinib and decitabine in patients with myeloproliferative neoplasm in accelerated and blast phase

Blood Advances(2020)10.1182/bloodadvances.2020002119

N/A

2.2DataRank · unranked

73 citations

Raajit K. Rampal, Heidi Kosiorek, Rupali Bhave, Elizabeth O. Hexner, Eunice S. Wang +22 more

Cancer therapy shapes the fitness landscape of clonal hematopoiesis

Nature Genetics(2020)10.1038/s41588-020-00710-0

N/A

0.993DataRank · unranked

750 citations

Ryan Ptashkin, Teng Gao, Lior Z. Braunstein, Sean M. Devlin, Daniel J. Kelly +59 more

Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia

American Journal of Hematology(2022)10.1002/ajh.26757

N/A

0DataRank · unranked

25 citations

Andriy Derkach, Noushin Farnoud, Jan Philipp Bewersdorf, Troy M. Robinson, Christopher Famulare +35 more

Characterization of disease-propagating stem cells responsible for myeloproliferative neoplasm–blast phase

JCI Insight(2022)10.1172/jci.insight.156534

N/A

0DataRank · unranked

6 citations

Raajit K. Rampal, Cing Siang Hu, Joseph Tripodi, Noushin Farnoud, Bruce Petersen +12 more

Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia: an appraisal of the new WHO and IC classifications and ELN risk stratification

medRxiv(2022)10.1101/2022.12.26.22283876

N/A

0DataRank · unranked

0 citations

David Nemirovsky, Christopher Famulare, Noushin Farnoud, Abhinita Mohanty, Zoe S. Stone-Molloy +22 more

A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0276

N/A

0DataRank · unranked

34 citations

Anna Ritá Migliaccio, Heidi Kosiorek, Rupali Bhave, Jeanne Palmer, Andrew Kuykendall +29 more

Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia

Blood Advances(2023)10.1182/bloodadvances.2023009675

N/A

0DataRank · unranked

19 citations

David Nemirovsky, Christopher Famulare, Noushin Farnoud, Abhinita Mohanty, Zoe S. Stone-Molloy +22 more

LKB1/ STK11 Is a Tumor Suppressor in the Progression of Myeloproliferative Neoplasms

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1353

N/A

0DataRank · unranked

46 citations

Praveen Suraneni, Hamza Celik, Andrew Volk, Qiang Wen, Te Ling +20 more

Genomic and evolutionary portraits of disease relapse in acute myeloid leukemia

Leukemia(2021)10.1038/s41375-021-01153-0

N/A

0DataRank · unranked

19 citations

Yaseswini Neelamraju, Timour Baslan, Duane C. Hassane, Agata Gruszczyńska, Marc Robert de Massy +19 more